Wells Fargo & Company Ginkgo Bioworks Holdings, Inc. Call Options Transaction History
Wells Fargo & Company
- $434 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding DNA
# of Institutions
41Shares Held
48.1MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY42MShares$365 Million0.0% of portfolio
-
Titleist Asset Management, Ltd. San Antonio, TX2.31MShares$20.1 Million0.92% of portfolio
-
Putnam Investments LLC Boston, MA1.5MShares$13.1 Million0.0% of portfolio
-
Credit Suisse Ag Zurich, V81.15MShares$9.97 Million0.0% of portfolio
-
Benjamin F. Edwards & Company, Inc. St. Louis, MO235KShares$2.04 Million0.0% of portfolio
About Ginkgo Bioworks Holdings, Inc.
- Ticker DNA
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,287,779,968
- Market Cap $11.2B
- Description
- Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...